This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
ChIPAb+ Dimethyl-Histone H3 (Lys9) - ChIP Validated Antibody and Primer Set
catalog :
17-648
quantity :
25 assays
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot, immunoprecipitation, chromatin immunoprecipitation
citations: 4
Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
product information
Catalog Number :
17-648
Subcategory :
Epigenetics & Nuclear Function
Product Name :
ChIPAb+ Dimethyl-Histone H3 (Lys9) - ChIP Validated Antibody and Primer Set
Product Type :
Antibodies
Clonality :
Polyclonal Antibody
Gene ID :
Q66I33
Host Name :
Rabbit
Antigen :
Dimethyl-Histone H3 (Lys9)
Conjugate :
Serum
Product Description :
ChIPAb+ Dimethyl-Histone H3 (Lys9) - ChIP Validated Antibody and Primer Set
Cross Reactivity :
Human;Mouse;Mammals
Immunogen :
The dimethyl-histone H3 (Lys9) rabbit serum is made against a KLH-conjugated, branched synthetic peptide containing the sequence . Rme2KSTG. , in which me2K corresponds to dimethyl-lysine at residue 9 of human histone H3
Specificity :
Dimethyl-Histone H3 (Lys9)
Package Size :
25 assays
Uses :
Western Blotting;Immunoprecipitation;Chromatin Immunoprecipitation (ChIP)
Storage :
Stable for 1 year at -20°C from date of receipt
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments